SE7701552L - Terapeutiska medel - Google Patents

Terapeutiska medel

Info

Publication number
SE7701552L
SE7701552L SE7701552A SE7701552A SE7701552L SE 7701552 L SE7701552 L SE 7701552L SE 7701552 A SE7701552 A SE 7701552A SE 7701552 A SE7701552 A SE 7701552A SE 7701552 L SE7701552 L SE 7701552L
Authority
SE
Sweden
Prior art keywords
compounds
allergic
therapeutic medicines
ethylethoxymethylene
cyanoacetate
Prior art date
Application number
SE7701552A
Other languages
English (en)
Other versions
SE433494B (sv
Inventor
P F Judy
R A Partyka
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/748,851 external-priority patent/US4082751A/en
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE7701552L publication Critical patent/SE7701552L/sv
Publication of SE433494B publication Critical patent/SE433494B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7701552A 1976-02-13 1977-02-11 Analogiforfarande for framstellning av tetrazolyl-pyrimidin-4-on-derivat SE433494B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65778776A 1976-02-13 1976-02-13
US05/748,851 US4082751A (en) 1976-02-13 1976-12-08 Therapeutic agents

Publications (2)

Publication Number Publication Date
SE7701552L true SE7701552L (sv) 1977-09-23
SE433494B SE433494B (sv) 1984-05-28

Family

ID=27097492

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7701552A SE433494B (sv) 1976-02-13 1977-02-11 Analogiforfarande for framstellning av tetrazolyl-pyrimidin-4-on-derivat

Country Status (14)

Country Link
JP (1) JPS52118481A (sv)
AU (1) AU508970B2 (sv)
CA (1) CA1083152A (sv)
CH (1) CH635339A5 (sv)
DE (1) DE2705609A1 (sv)
DK (1) DK149044C (sv)
FI (1) FI62533C (sv)
FR (1) FR2340943A1 (sv)
GB (1) GB1541351A (sv)
IE (1) IE44603B1 (sv)
LU (1) LU76722A1 (sv)
NL (1) NL173055C (sv)
SE (1) SE433494B (sv)
YU (1) YU41567B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419357A (en) * 1982-01-18 1983-12-06 The Dow Chemical Company 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones
CN101747282A (zh) * 2008-12-10 2010-06-23 上海特化医药科技有限公司 一类含有嘧啶酮苯基的化合物、其药物组合物及其制备方法和用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883653A (en) * 1972-10-24 1975-05-13 Pfizer Method of preventing asthmatic symptoms

Also Published As

Publication number Publication date
JPS52118481A (en) 1977-10-04
FI62533C (fi) 1983-01-10
FR2340943A1 (fr) 1977-09-09
NL173055C (nl) 1983-12-01
DE2705609A1 (de) 1977-08-25
FI62533B (fi) 1982-09-30
AU508970B2 (en) 1980-04-17
IE44603B1 (en) 1982-01-27
FI770427A (sv) 1977-08-14
YU35477A (en) 1982-10-31
AU2189577A (en) 1978-08-10
YU41567B (en) 1987-10-31
DE2705609C2 (sv) 1988-12-15
LU76722A1 (sv) 1977-08-18
DK57377A (da) 1977-08-14
FR2340943B1 (sv) 1981-01-09
NL7701483A (nl) 1977-08-16
DK149044B (da) 1985-12-30
CA1083152A (en) 1980-08-05
IE44603L (en) 1977-08-13
NL173055B (nl) 1983-07-01
JPS6139947B2 (sv) 1986-09-06
SE433494B (sv) 1984-05-28
GB1541351A (en) 1979-02-28
DK149044C (da) 1986-06-02
CH635339A5 (en) 1983-03-31

Similar Documents

Publication Publication Date Title
ES473451A1 (es) Un procedimiento para la preparacion de derivados de imida- zol.
LV10575A (lv) Izoksazoi-4-karbonskabes amids un hidroksialkiliden-cianetikskabes amids sos savienojumus saturosi astniecibas lidzekli un to pielietojums
BG30612A3 (en) Antidot means
ES462065A1 (es) Procedimiento para la preparacion de derivados de tiazolidi-na.
ATE102930T1 (de) Heterozyklische verbindungen, deren herstellung und medikamente diese enthaltend.
ES8200094A1 (es) Procedimiento para la obtencion de alquilureas
DE3483798D1 (de) Dihydrodibenzocycloheptylidenethylamin-derivate.
AR039345A1 (es) Derivados de acido amino-1h-indol-2-carboxilico 3-sustituidos y de acido amino-benzo(b)-tiofeno-2-carboxilico 3-sustituidos como inhibidores de la expresion del gen de la inteleuquina-4
SE7604476L (sv) Forfarande for framstellning av 1-(3,3,3-triarylpropyl)-4-fenyl-4-piperidinmetanolforeningar
ATE40369T1 (de) Purinderivate.
FR2367743A1 (fr) Derives aryle conten
SE7605819L (sv) Nya propargyl-2-fenylaminoimidazolin-(2), dess syraadditionssalter, lekemedel innehallande dessa och forfarande for framstellning derav
SE8202034L (sv) Nytt kemiskt forfarande for framstellning av propionitrilderivat
SE7705310L (sv) Kinazolinderivat
SE7411243L (sv)
SE7701552L (sv) Terapeutiska medel
ATE1625T1 (de) Isoxazolylcarbonsaeureanilide, ihre herstellung, diese enthaltende fungizide mittel und verfahren zur bekaempfung von pilzen.
ATE116650T1 (de) Sulfonylamin substituierte bizyklische hydroxansäurederivate.
SE7811455L (sv) 2-imino-imidazolidin-derivat
FI803202L (fi) Fosfonohydroxiaettiksyra foerfarande foer dess framstaellning och dess anvaendning saosom laekemedel
NO301826B1 (no) Heterotricyklisk substituerte fenylcykloheksankarboksylsyrederivater, legemidler inneholdende dem og deres anvendelse for fremstilling av legemidler
ATE58532T1 (de) (2-amino-4-aryl-thiazol-5-yl)aethanol, und deren derivate mit diuretischer aktivitaet und verfahren zu deren herstellung.
ATE3769T1 (de) 1-imidazol-2-yliden-3-thienyl-harnstoffderivate verfahren zu deren herstellung und pharmazeutische zusammensetzungen.
ATE88176T1 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
ATE59041T1 (de) Hexahydropyrrolo(2,1-a)isochinolinderivate.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7701552-7

Effective date: 19920904

Format of ref document f/p: F